Elevation Oncology, Inc. reports

Company location: Boston, MA
Fiscal year end: 31 December

Elevation Oncology, Inc. has filed 298 SEC EDGAR filings since 19 Jul 2019

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 251-275 of 298 matching filings.

Per page

25

Current page

11

4

FORM 4 SUBMISSION

Filing date: 01 Jul 2021
Reporting date: 29 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Jul 2021
Reporting date: 29 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Jul 2021
Reporting date: 29 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Jul 2021
Reporting date: 29 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 29 Jun 2021
Reporting date: 29 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

424B1 File 333-256787

424B1

Filing date: 25 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-257377

FORM S-8

Filing date: 25 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date: 24 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-256787

EFFECT filing

Filing date: 24 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .